Literature DB >> 28490987

Stereotactic body radiation therapy for liver metastasis - The linac-based Greater Poland Cancer Centre practice.

Magdalena Fundowicz1, Marta Adamczyk2, Anna Kołodziej-Dybaś3.   

Abstract

AIM: The main purpose of this work is to give a technical description and present the properties of the liver SBRT protocol implemented in the Greater Poland Cancer Centre (GPCC) in Poznan, Poland.
BACKGROUND: Stereotactic body radiation therapy (SBRT) for liver metastasis is a non-invasive therapeutic option which enables irradiation of a small target in the body with a high dose.
MATERIALS AND METHODS: This study presents details of our linac-based liver SBRT protocol. Special emphasis has been placed on fiducial implantation, patient preparation (CT scanning, immobilization), treatment planning, and its implementation.
RESULTS: The liver SBRT treatment course implemented in the GPCC consists of three fractions to deliver a total of 45 Gy. Fraction delivery details with description of patient positioning (localization of liver metastasis) are presented below.
CONCLUSIONS: The literature validation of the assumptions concerning the steps of the GPCC linac-based liver SBRT procedure show their potential for an effective and patient friendly implementation.

Entities:  

Keywords:  Fiducial markers; Liver metastases; Stereotactic body radiation therapy (SBRT)

Year:  2017        PMID: 28490987      PMCID: PMC5411890          DOI: 10.1016/j.rpor.2017.02.008

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  29 in total

1.  Stereotactic body radiation therapy for oligometastases.

Authors:  Simon S Lo; Bin S Teh; Nina A Mayr; Thomas E Olencki; Jian Z Wang; John C Grecula; Jiade J Lu; Robert D Timmerman
Journal:  Discov Med       Date:  2010-09       Impact factor: 2.970

2.  Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial.

Authors:  Marta Scorsetti; Stefano Arcangeli; Angelo Tozzi; Tiziana Comito; Filippo Alongi; Pierina Navarria; Pietro Mancosu; Giacomo Reggiori; Antonella Fogliata; Guido Torzilli; Stefano Tomatis; Luca Cozzi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2013-02-20       Impact factor: 7.038

Review 3.  Stereotactic body radiation therapy for liver metastases.

Authors:  Marta Scorsetti; Elena Clerici; Tiziana Comito
Journal:  J Gastrointest Oncol       Date:  2014-06

4.  Stereotactic body radiotherapy for superior vena cava syndrome.

Authors:  Joshua T McKenzie; Emory McTyre; Dan Kunaprayoon; Kevin P Redmond
Journal:  Rep Pract Oncol Radiother       Date:  2013-01-16

5.  Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases.

Authors:  Alan W Katz; Madeleine Carey-Sampson; Ann G Muhs; Michael T Milano; Michael C Schell; Paul Okunieff
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-12-29       Impact factor: 7.038

Review 6.  Radiation therapy for liver metastases.

Authors:  Alejandra Mendez Romero; Morten Høyer
Journal:  Curr Opin Support Palliat Care       Date:  2012-03       Impact factor: 2.302

Review 7.  Stereotactic body radiation therapy for extracranial oligometastases: does the sword have a double edge?

Authors:  Madeleine Carey Sampson; Alan Katz; Louis S Constine
Journal:  Semin Radiat Oncol       Date:  2006-04       Impact factor: 5.934

8.  Stereotactic radiotherapy of primary liver cancer and hepatic metastases.

Authors:  Joern Wulf; Matthias Guckenberger; Ulrich Haedinger; Ulrich Oppitz; Gerd Mueller; Kurt Baier; Michael Flentje
Journal:  Acta Oncol       Date:  2006       Impact factor: 4.089

9.  Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors.

Authors:  Alejandra Méndez Romero; Wouter Wunderink; Rob M van Os; Peter J C M Nowak; Ben J M Heijmen; Joost J Nuyttens; Rene P Brandwijk; Cornelis Verhoef; Jan N M Ijzermans; Peter C Levendag
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-11-08       Impact factor: 7.038

10.  A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.

Authors:  Ingrid Fumagalli; Jean-Emmanuel Bibault; Sylvain Dewas; Andrew Kramar; Xavier Mirabel; Bernard Prevost; Thomas Lacornerie; Hajer Jerraya; Eric Lartigau
Journal:  Radiat Oncol       Date:  2012-09-27       Impact factor: 3.481

View more
  3 in total

1.  Editorial.

Authors:  Miquel Macià; Carmen Llacer-Moscardo
Journal:  Rep Pract Oncol Radiother       Date:  2016-10-15

2.  Stereotactic body radiation therapy for liver metastases: Clinical outcomes and literature review.

Authors:  Cuauhtémoc de la Peña; María F Gonzalez; César González; Joel M Salazar; Benjamín Cruz
Journal:  Rep Pract Oncol Radiother       Date:  2020-05-23

3.  Estimating intrafraction tumor motion during fiducial-based liver stereotactic radiotherapy via an iterative closest point (ICP) algorithm.

Authors:  Wu-Zhou Li; Zhi-Wen Liang; Yi Cao; Ting-Ting Cao; Hong Quan; Zhi-Yong Yang; Qin Li; Zhi-Tao Dai
Journal:  Radiat Oncol       Date:  2019-10-29       Impact factor: 3.481

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.